Warning! GuruFocus detected
1 Severe warning sign
with 0RDB.
Try a 7-Day Free Trial
to check it out.
What is a stock summary page? Click here for an overview.
Business Description
Oryzon Genomics SA
ISIN : ES0167733015
Compare
Compare
Traded in other countries / regions
ORY.Spain0RDB.UKORN.GermanyORYZF.USAORY.Mexico IPO Date
2015-12-17Description
Oryzon Genomics SA is a clinical stage biopharmaceutical company and engaged in the development of epigenetics-based therapeutics. It is engaged in the field of epigenetic medicine and in the development of therapeutic, biological solutions for cancer and neurodegenerative diseases.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.63 | |||||
| Equity-to-Asset | 0.79 | |||||
| Debt-to-Equity | 0.14 | |||||
| Debt-to-EBITDA | 2.32 | |||||
| Interest Coverage | 6.54 | |||||
| Piotroski F-Score | 3/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 5.3 | |||||
| 3-Year EPS without NRI Growth Rate | 3.2 | |||||
| 3-Year FCF Growth Rate | 2.3 | |||||
| 3-Year Book Growth Rate | -2.3 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 34.19 | |||||
| 9-Day RSI | 45.88 | |||||
| 14-Day RSI | 51.76 | |||||
| 3-1 Month Momentum % | 81.17 | |||||
| 6-1 Month Momentum % | 37.3 | |||||
| 12-1 Month Momentum % | 46.14 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -4.9 | |||||
| Shareholder Yield % | -1.12 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -4.73 | |||||
| ROA % | -3.68 | |||||
| ROIC % | 4.04 | |||||
| 3-Year ROIIC % | 1.15 | |||||
| ROC (Joel Greenblatt) % | 1179.58 | |||||
| ROCE % | 5.71 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Forward PE Ratio | 316.67 | |||||
| PB Ratio | 1.98 | |||||
| Price-to-Tangible-Book | 1.98 | |||||
| EV-to-EBIT | 33.72 | |||||
| EV-to-Forward-EBIT | 7.35 | |||||
| EV-to-EBITDA | 33.72 | |||||
| EV-to-Forward-EBITDA | 7.32 | |||||
| EV-to-Forward-Revenue | 10.01 | |||||
| EV-to-FCF | -14.19 | |||||
| Earnings Yield (Greenblatt) % | 2.96 | |||||
| FCF Yield % | -7.88 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Oryzon Genomics SA Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | |||
| EPS (TTM) (€) | -0.064 | ||
| Beta | 0.35 | ||
| 3-Year Sharpe Ratio | 0.04 | ||
| 3-Year Sortino Ratio | 0.11 | ||
| Volatility % | 84.93 | ||
| 14-Day RSI | 51.76 | ||
| 14-Day ATR (€) | 0.205136 | ||
| 20-Day SMA (€) | 3.11075 | ||
| 12-1 Month Momentum % | 46.14 | ||
| 52-Week Range (€) | 1.402 - 3.625 | ||
| Shares Outstanding (Mil) | 64.71 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Oryzon Genomics SA Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Oryzon Genomics SA Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Oryzon Genomics SA Frequently Asked Questions
What is Oryzon Genomics SA(LTS:0RDB)'s stock price today?
The current price of LTS:0RDB is €3.00. The 52 week high of LTS:0RDB is €3.63 and 52 week low is €1.40.
When is next earnings date of Oryzon Genomics SA(LTS:0RDB)?
The next earnings date of Oryzon Genomics SA(LTS:0RDB) is 2025-05-06 Est..
Does Oryzon Genomics SA(LTS:0RDB) pay dividends? If so, how much?
Oryzon Genomics SA(LTS:0RDB) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers